Jeena Sikho Lifecare
Market cap ₹3,684 Cr
- P/E
- 15.61
- Day range
- ₹293.50 – ₹305.00
- 52-week range
- ₹280.00 – ₹809.00
- Volume
- 9.12 L
- Open
- ₹299.95
- Prev close
- ₹299.95
Latest results · Q2 FY27(consolidated)Revenue ₹235 Cr+23.9%Profit ₹37 Cr-37.7%Margin 15.6%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
JSLL in NSE indices and F&O
Research profile
Composite 39 / 100Factor percentiles
Derived metrics
- Earn. yield
- 6.4%
- Graham no.
- ₹124.14
- vs Graham
- -58.1%
- ROE ÷ P/B
- 8.2%
- 12-1 mom.
- -46.7%
- Return / vol
- -1.08
- Magic Formula
- #10
- FCF yield
- 6.0%
Appears in 15 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 90 in Consumer| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Titan CompanyTITAN | ₹4.12 L Cr | 58.67 | 23.83 | 37.1% | 21.0% | 14.0% | 1.51 | +10.1% |
| Asian PaintsASIANPAINT | ₹2.47 L Cr | 51.14 | 11.23 | 21.6% | 26.0% | 16.0% | 0.21 | +16.9% |
| Avenue SupermartsDMART | ₹2.26 L Cr | 72.59 | 8.60 | 12.9% | 17.0% | 7.0% | 0.16 | +17.8% |
| TrentTRENT | ₹1.70 L Cr | 89.73 | 21.75 | 27.7% | 28.0% | 18.0% | 0.30 | +21.9% |
| Lenskart SolutionsLENSKART | ₹1.27 L Cr | 162.33 | 13.71 | 6.8% | 8.0% | 22.0% | 0.37 | +35.7% |
| The Indian Hotels CompanyINDHOTEL | ₹1.25 L Cr | 56.35 | 9.29 | 18.6% | 17.0% | 28.0% | 0.25 | +21.7% |
| MeeshoMEESHO | ₹1.17 L Cr | 188.64 | 27.61 | -46.6% | -40.0% | -6.0% | 0.01 | +34.4% |
| Jeena Sikho LifecareJSLL | ₹3,684 Cr | 15.61 | 7.45 | 61.4% | 64.0% | 31.0% | 0.32 | +23.7% |
| Sector median | ₹10,665 Cr | 40.83 | 4.83 | 13.0% | 15.0% | 12.5% | 0.27 | +19.1% |
Sector as classified in the tracked universe; medians use every tracked Consumer company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 7h agoHeadlines about Jeena Sikho Lifecare from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 18.0
- Price / Book
- 7.12
- ROE (FY26)
- 61.4%
- ROCE (latest year)
- 64%
- Dividend yield
- 1.45%
Moving averages (NSE)
- 20-day
- ₹338.59
- Price below
- 50-day
- ₹415.81
- Price below
- 200-day
- ₹565.24
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- FII
- DII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Financial statements
| Line item | Jun 2024 (S) | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 114 | 116 | 139 | 174 | 190 | 222 | 216 | 224 | 235 |
| Expenses | 75 | 74 | 86 | 93 | 96 | 98 | 121 | 138 | 132 | 163 |
| Operating Profit | 25 | 40 | 30 | 46 | 79 | 92 | 101 | 78 | 92 | 72 |
| OPM % | 25% | 35% | 26% | 33% | 45% | 48% | 45% | 36% | 41% | 31% |
| Other Income | 3 | 3 | 0 | 0 | 1 | 1 | 3 | 3 | 14 | -2 |
| Interest | 1 | 2 | 4 | 3 | 2 | 4 | 3 | 4 | 3 | 4 |
| Depreciation | 5 | 6 | 8 | 9 | 10 | 10 | 11 | 16 | 15 | 16 |
| Profit before tax | 21 | 35 | 18 | 34 | 69 | 79 | 89 | 61 | 88 | 50 |
| Tax % | 23% | 25% | 26% | 25% | 25% | 25% | 25% | 26% | 25% | 26% |
| Net Profit | 16 | 27 | 13 | 25 | 51 | 59 | 67 | 45 | 66 | 37 |
| EPS in Rs | ₹1.30 | ₹2.14 | ₹1.06 | ₹2.04 | ₹4.13 | ₹4.73 | ₹5.36 | ₹3.63 | ₹5.31 | ₹2.95 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
+15 days since Mar 2020 (S)
-234 days since Mar 2020 (S)
-76 days since Mar 2020 (S)
-143 days since Mar 2020 (S)
+30 days since Mar 2020 (S)
Strengths, risks & growth
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
Strengths
- Company is expected to give good quarter
- Debtor days have improved from 49.0 to 31.8 days.
- Company's working capital requirements have reduced from 21.2 days to 14.6 days
Risks
- Stock is trading at 7.46 times its book value
- Promoter holding has decreased over last 3 years: -4.24%
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- +58%
- TTM
- +45%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- +88%
- TTM
- +44%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- —
- 3 Years
- +29%
- 1 Year
- -57%
Return on Equity
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- Last Year
- +61%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 63.62% | 63.62% | 63.62% | 63.67% | +0.05 pp |
| FII | 6.31% | 6.17% | 4.78% | 4.49% | -0.29 pp |
| DII | 0.11% | 0.46% | 0.36% | 0.53% | +0.17 pp |
| Public | 29.97% | 29.77% | 31.24% | 31.29% | +0.05 pp |
Filed with NSE for Sept 2026: promoters 63.67%, public 36.33%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 0.10% (0.00 pp)- Promoters63.7%
- Foreign institutions4.5%
- Mutual funds0.1%
- Insurance0.0%
- Other domestic institutions0.4%
- Retail15.8%
- Others15.5%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 0.12% | 0.19% | -0.11 pp |
| Groww Nifty Total Market Index Fund | 0.00% | 0.01% | -0.01 pp |
| Angel One Nifty Total Market Index Fund | 0.00% | 0.01% | -0.01 pp |
| Bandhan Nifty Total Market Index Fund | 0.00% | 0.01% | -0.01 pp |
| Mirae Asset Nifty Total Market Index Fund | 0.00% | 0.01% | -0.01 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 55.1%
- Downside volatility
- 55.4%
- Worst 5% of days
- 5.3%
- Average of that tail
- 8.5%
- Max drawdown (1Y)
- 64.6%
- Below its peak
- 64.6%
Against the market
- Beta vs Nifty 50
- 1.19
- Correlation
- 0.29
- Relative strength (3M)
- -46.6%
- ATR (14)
- 7.2%
Return
- Return 1M
- -23.7%
- Return 3M
- -42.7%
- Return 6M
- -53.1%
- Return 1Y
- -59.3%
- vs 200-day average
- -47.6%
Momentum
- RSI (14) · oversold
- 29.7
- MACD histogram
- 0.48
- Stochastic %K
- 17.8
- ADX (14)
- 42.4
- +DI / −DI
- 14.8 / 42.9
- Money flow index
- 26.1
Participation
- Delivery (20d avg)
- 43.0%
- vs its 60-day baseline
- -1.9 pts
- Volume vs 20-day
- -0.0σ
- Close vs day's VWAP
- -0.6%
- 52-week position
- 0 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 31 Mar 2026.
No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.
- Free cash flow
- ₹220 Cr
- FCF yield
- 6.0%
- Cash conversion
- 1.14
- Accruals ratio
- -0.048
- Net debt
- ₹111 Cr
- Net debt / equity
- 0.24
- EV / sales
- 4.23
- Capex intensity
- 4.2%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Corporate actions
- dividend₹4.50
Dividend - Rs 4.50 Per Share
21 Sept 2026ex-date - dividendNot available — not reported in this filing
Dividend - Re 1.10 Per Share
22 Sept 2025ex-date
Company announcements
Allotment of 23,374 Equity Shares under the Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2024 ("ESOS 2024")
Please refer to the attached pdf
Launch of New Products
NABH Accreditation for Raiput Hospital
Scrutinizer's Report and Voting Result of 9th AGM of the company Held on 28.09.2026
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavna Grover
Disclosure under Regulation 29(2), details as attached in the PDF.
Disclosure under Regulation 29(2), details as attached in the PDF.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavna Grover
Proceedings of 9th AGM of the Company held on 28.09.2026
Intimation for Closure of Trading Window for the Quarter and half year ended 30.09.2026
Intimation of In-Principle Approval from BSE Limited under Jeena sikho Employees Stock Option Scheme, 2024 (ESOS 2024)
Intimation of Schedule of Analyst / Investor Meet/ Conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Launch of New products.
Please refer to the attached PDF for details.
Filed with BSE (scrip 544476); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026SlidesRecording
- Aug 2026TranscriptSlidesRecording
- Jun 2026TranscriptSlidesRecording
- May 2026Slides
- Feb 2026TranscriptSlidesRecording
- Nov 2025TranscriptSlidesRecording
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 15 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Jeena Sikho Lifecare: common questions
Answered from the figures on this page.